Endowed Chair of Rheumatology retires from University of Edinburgh
Professor Stuart Ralston retired from his position as Arthritis UK’s Endowed Chair of Rheumatology at the University of Edinburgh and a Festschrift event was held in his honour (January 29).
Professor Ralston has had a decorated career in rheumatology, including holding the position as Arthritis UK’s Endowed Chair for over 20 years. His research focused on the management of bone and joint disease, with a special interest in Paget’s disease.
Professor Ralston’s research has benefitted patients and influenced policy. His medical education contributions have benefitted students globally and his contribution to medicines regulation has saved many lives, notably through his oversight of emergency approval of COVID-19 vaccines as chair of the Commission on Human Medicines.
He was recently (December 2025) duly recognised for these contributions by being awarded the Royal Society of Edinburgh Sir James Black Medal.
Professor Ralston said: “A highlight of my career has been the work in Paget’s disease of the bone, looking at the genetic basis of the condition and doing clinical trials to establish optimal treatment strategies.
“I’ve also enjoyed bringing in new people and seeing them make their own way over the years. It’s been a privilege. I have been lucky to reach the top of my profession.
“While I will be sad to leave, I have still got some outstanding projects to finish off during my retirement and am looking forward to having more time to spend with my family and friends.”
To commemorate his achievements Professor Ralston attended a Festschrift event, where his closest colleagues and collaborators gathered to share warm remarks and celebrate his contributions to the field.
Arthritis UK’s Head of Research Strategy, Sarah Rudkin, attended the event and said: “Professor Ralston has led the field on the molecular and genetic basis of osteoporosis and Paget’s disease for the benefit of people living with these conditions.
“We greatly value his long-standing relationship with Arthritis UK and the varied contributions that he has made to the work of the charity. It’s been a privilege to support him throughout his professional endeavours, and we wish him a joyful retirement.”
Professor Cosimo de Bari, specialist in osteoarthritis and stem cell therapies, has been appointed the new Arthritis UK Endowed Chair of Rheumatology.
Deborah Alsina MBE, Arthritis UK Chief Executive, said: “The position of Endowed Chair at Edinburgh was established to create a nucleus for rheumatology research.
“Professor Ralston’s work has been a testament to our joint commitment to expanding knowledge, improving practice and bettering the lives of those who live who live with these often-debilitating conditions.
“It has been an honour to endorse his successes from his pivotal research developments and clinical trials to his PhD mentorships. He has truly been instrumental in defining the contemporary landscape of rheumatology.
“We are delighted to welcome Professor Cosimo de Bari to this prestigious position and are eager to support him as we journey together towards a cure.”
Professor David Argyle, Head of the College of Medicine and Veterinary Medicine, University of Edinburgh, said: “Established nearly 50 years ago, the Endowed Chair recognises the University’s long-standing excellence in the field of rheumatology.
“Professor Ralston has been central to this endeavour, advancing research to improve patient outcomes worldwide.
“As we celebrate his achievements and bid him a congratulatory farewell, we are equally thrilled to welcome Professor Cosimo de Bari to the position, and look forward to continuing our valued partnership with Arthritis UK to champion innovative research.”